Structure and Biochemical Properties of Recombinant Human Dimethylglycine Dehydrogenase and Comparison to the Disease-Related H109R Variant Peter Augustin1, Altijana Hromic2, Tea Pavkov-Keller3, Karl Gruber2, and Peter Macheroux1 1 Institute of Biochemistry, Graz University of Technology, Graz, Austria 2 Institute of Molecular Biosciences, University of Graz, Graz, Austria 3 Austrian Centre of Industrial Biotechnology, Graz, Austria To whom correspondence should be addressed: Prof. Dr. Peter Macheroux, Graz University of Technology, Institute of Biochemistry, Petersgasse 12/II, A-8010 Graz, Telephone: +43-(0)316-873 6450; FAX: +43 (0)316-873 6952; E-mail:
[email protected] Running title: Human Dimethylglycine Dehydrogenase Article Abbreviations: AgDMGO, Arthrobacter globiformis dimethylglycine oxidase; DCPIP, 2,6- dichlorophenolindophenol; DMG, dimethylglycine; hDMGDH, human dimethylglycine dehydrogenase; hETF, human electron transferring flavoprotein; ETF-QO, ETF-ubiquinone oxidoreductase; hMCAD, human medium-chain acyl-CoA dehydrogenase; MRE, mean residue ellipticity; PMS, phenazine methosulfate; THF, tetrahydrofolate; WT, wild-type. Database: Structural data are available in the PDB database under the accession number 5L46. Keywords: Choline, dehydrogenase, electron transfer, flavin adenine dinucleotide (FAD), genetic disease, recombinant protein expression, tetrahydrofolate (THF), X-ray crystallography Article type : Original Article Conflict of interests: The authors declare no conflict of interests. This article has been